EEG Devices Market Is Expected To Grow At A CAGR Of 7.6% from 2014 to 2025: Grand View Research, Inc.

The global EEG devices/systems market is expected to reach a value of USD 1.40billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of neurological disorders such as epilepsy, sleeping disorders, brain tumor, Parkinson’s disease, and stroke is a major factor anticipated to drive market growth during the forecast period. According to WHO, over 50 million people are affected by epilepsy; and more than 35.6 million people worldwide are suffering from Alzheimer’s disease and dementia. Thus, the increasing prevalence of neurological disorders leads to rising demand for EEG systems and equipment. In addition, growing awareness about neurological diseases in developed and developing regions is expected to boost the market.

Increasing funding for neuroscience R&D by governments is another main factor contributing to the market growth. For instance, in June 2014, the U.S. Department of Defense granted USD 400,000 to University of Texas at San Antonio for the purchase of two EEG systems intended for advance research on brain-machine interaction. Also, technological advancement in these systems propels its adoption for detection of abnormalities associated with electrical activity of the brain. Thus, government initiatives and technological advancement are expected to drive the growth of the sector in the near future.

Browse full research report on Electroencephalography Devices Market: http://www.grandviewresearch.com/industry-analysis/electroencephalography-eeg-systems-devices-market    


Further Key Findings From the Study Suggest:

  • The 32-channel EEG segment was the highest revenue generating segment of the market in 2015. The technological advancement in 32-channel EEG products propels the segment growth
  • In 2015, the standalone devices segment was the highest revenue grossing segment of the market due to its high application in hospitals and diagnostics centers
  • The hospitals segment held the largest revenue share in the market in 2015, owing to the increasing number of patients suffering from neurological disorders. The rising geriatric population is another major factor responsible for the growth of the hospitals segment during study period
  • North America accounted for the largest revenue share of the EEG devices market in the year 2015. The availability of insurance coverage for brain monitoring and well-developed healthcare infrastructure is anticipated to drive demand for EEG products in the region during the forecast period
  • Some of the key companies are Natus Medical, Inc.; NeuroWave Systems, Inc.; Electrical Geodesics, Inc.; Medtronic; Compumedics Ltd.; Cadwell Laboratories, Inc.; Noraxon U.S.A. Inc.; and Nihon Kohden America, Inc.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices 
    
Grand View Research has segmented the EEG Devices market on the basis of product, type, end use, and region:

EEG Devices Product Outlook (Revenue, USD Million; 2014 - 2025)
  • 8-channel EEG
  • 21-channel EEG
  • 25-channel EEG
  • 32-channel EEG
  • 40-channel EEG
  • Multichannel EEG
EEG Devices Type Outlook (Revenue, USD Million; 2014 - 2025)
  • Standalone devices
  • Portable devices
EEG Devices End-Use Outlook (Revenue, USD Million; 2014 - 2025)
  • Hospitals
  • Diagnostic Centers
  • Others
EEG Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • MEA
    • South Africa
Access Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-electroencephalography-eeg-systems-devices-market   
                    
About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.


For more information: http://www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more